Skip Main Navigation
Page Content

Save This Event

Event Saved

From Across the Pond: Expert Insight on Life Science Start-ups

JLABS @ Toronto

Tuesday, November 7, 2017 from 4:00 PM to 7:00 PM (EST)

From Across the Pond: Expert Insight on Life Science...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Presentation and Lunch   more info Nov 6, 2017 CA$15.00 CA$1.51
Media/Press   more info Nov 1, 2017 Free CA$0.00
Volunteer   more info Nov 1, 2017 Free CA$0.00

Share From Across the Pond: Expert Insight on Life Science Start-ups

Event Details

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for a special presentation from Jeanne Bolger on learning the tricks of the trade in preparing a non-confidential deck and executive summary. She will share practical tips on becoming more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising.

After Jeanne’s presentation, join us for a panel discussion on becoming a life science entrepreneur in both Canada and Ireland.

Jeanne Bolger | VP, Venture Investments, Johnson & Johnson Innovation - JJDC read bio»
Alan Hobbs | Manager High Potential Start Ups, Enterprise Ireland read bio»
Sandra Ganly | Operations Manager , BioInnovate read bio»

4:00 | Registration Opens and Networking
4:30 | Presentation
5:15 | Q&A
5:30 | Panel
6:00 | Cocktail Reception
7:00 | Program Close

Who should attend:
This event is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.

$15 | General Public
Includes presentation, Q&A, and lunch.

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Speaker Biographies:
Jeanne Bolger | VP, Venture Investments, Johnson & Johnson Innovation - JJDC
Jeanne joined Johnson & Johnson Innovation - JJDC as Vice President, Venture Investments, in February 2013. She is based in London, UK at the Johnson & Johnson Innovation Centre. Jeanne's responsibilities are focused on investing in and managing portfolio investments in the pharmaceuticals and biotechnology areas in Europe.
Jeanne has over 25 years of pharmaceutical industry experience in management roles across R+D, Commercial and Business Development. She spent 11 years in Licensing and Acquisition, most recently as Global Head of Scientific Licensing for Johnson & Johnson's Pharmaceutical business, having joined the Johnson & Johnson Family of Companies in 2005 from the Business Development group at GSK.
In 2009, Jeanne became VP Alliance Management and Board Director at Janssen Alzheimer Immunotherapy, working with Pfizer and Elan on immunotherapies targeting beta amyloid for Alzheimer's disease.
Jeanne received her medical degree from University College Dublin. She also holds diplomas in Child Health (NUI) and in Finance and Accounting (ACCA). She is a Fellow of the Royal Academy of Medicine of Ireland (RAMI). She has served as the sole pharmaceutical industry representative on two Irish government taskforces seeking to enhance the commercialization of IP from Irish academic centres. She is a visiting lecturer on the MSc Pharmaceutical Medicine curriculum at Trinity College in Dublin, Ireland.

Alan Hobbs | Manager High Potential Start Ups, Enterprise Ireland
Alan manages the Irish Government’s lifescience High Potential Start-Up team who work with the best emerging Bio, Pharma and Medical Device companies in Ireland. He has 27 years global experience living and working in China, Silicon Valley, Taiwan, Korea and Ireland. Alan started his career working with “C” level executives in US and Asian Multinationals, selling Ireland as a HQ for their EMEA activities, he crossed over to the domestic side of economic development with roles in High Growth Markets, Corporate Communications and the Food sector. MBA graduate from Trinity College, currently lives in Dublin with Yvonne, Thomas and Conor, cats (Nellie and Bill) and Peanut the dog.

Enterprise Ireland is the Agency of the Irish Government responsible for the Development of Irish Industry. They work with 5000 clients across a wide range of sectors to help entrepreneurs start, scale and succeed in Global markets. More information available at:

Sandra Ganly | Operations Manager , BioInnovate
Sandra Ganly is a biomedical engineer with 14 years industrial and innovative product design experience in the medical device industry, progressing from technician and engineering roles to leadership positions in both Industry and Academia. She conducted her PhD research in Next Generation Coronary Stents and holds a senior research fellow position in NUI Galway’s Cardiovascular Research Institute where she continues her Preventive Cardiology and Risk-factor research interests. Since 2008, Sandra has maintained a role at the interface of academic, business and clinical communities, successfully managing multi-disciplinary projects for the benefit of the Medtech sector in Ireland – including the establishment of a Masters in Medical Technology Regulatory Affairs and BioInnovate Ireland - a Medical Device Innovation programme modelled on the prestigious Stanford Biodesign programme. As BioInnovate’s commercial lead, Sandra has assisted 19 technology solutions transition from their proof-of-concept origins in academia to raising investment in the market. Sandra was recently appointed as a Director in a newly funded mentor-centric Medtech Accelerator, BioExel, which aims to further support early stage and has a longer-term ambition to raise a consortium fund with Angels, Corporates and Government for Medtech start-ups in Ireland. Sandra is also the Chief Technology Officer for her own technology company, Contego Medical, focused on developing innovative solutions for unmet clinical needs in Sports-acquired Brain Injury.

Have questions about From Across the Pond: Expert Insight on Life Science Start-ups? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where

JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1

Tuesday, November 7, 2017 from 4:00 PM to 7:00 PM (EST)

  Add to my calendar


JLABS @ Toronto

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit

  Contact the Organizer
From Across the Pond: Expert Insight on Life Science Start-ups
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.